Newsletter | February 28, 2025

02.28.25 -- A Guide To Successful Product Launches For Small And Midsized Biotechs

SPONSOR

Webinar: Who’s In Charge of Your Trial? How to Ensure Effective Oversight and Leadership

Clinical trials in complex therapeutic areas require more than just a solid strategy—they demand proactive and engaged operational leadership from the sponsor side. Join our expert panel to discuss how an active and knowledgeable Clin Ops lead, in collaboration with an experienced outsourcing project lead, can drive informed decision-making, enhance efficiency, and ultimately ensure trial success. Click to learn more.

FEATURED ARTICLE

A Guide To Successful Product Launches For Small And Midsized Biotechs

Abhijit Naravane, a partner at PA Consulting, outlines strategies to help biopharma operations leaders successfully navigate the complexities of a product launch.

 

INDUSTRY INSIGHTS

What Does 2025 Hold For Pharma?

Look at what’s in store for pharmaceutical industry in 2025. While we see many recurring themes, 2025 promises to be filled with unexpected — and possibly unprecedented — developments.

PIPA Conference Explores The Key Role Of PV

The PIPA 2024 conference emphasized the importance of pharmacovigilance across the pharmaceutical industry, from mergers and acquisitions to clinical trials and health authority inspections.

6 Strategies To Engage Rare Disease PAOs Effectively

Patient advocacy organizations (PAOs) play a pivotal role in rare disease research by bridging the gap between patient communities and biotech companies.

Leveraging Digital Solutions To Reshape The CDMO Experience

CDMO customers consistently state that access to near real-time data is crucial to their ability to make timely, informed decisions, especially during early development.

CONTRIBUTE TO LIFE SCIENCE LEADER

Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director.